Skip to main content
Skip to main content
QMDT logo

Quick-Med Technologies, Inc. (QMDT) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0005 $0.00 (0.00%) |CouncilSplit View · 48 · C
Vol: 135K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Quick-Med Technologies, Inc. (QMDT) trades at $0.0005. Quick-Med Technologies, Inc. (QMDT) operates in the OTC Other tier, focusing on developing and marketing innovative technologies, potentially in areas like advanced wound care or infection control.

Price as of Sep 11, 2026 · Last analyzed: Sep 4, 2026

Quick-Med Technologies, Inc. (QMDT) operates in the OTC Other tier, focusing on developing and marketing innovative technologies, potentially in areas like advanced wound care or infection control. The company's key product line is not specified, but companies in this sector often focus on patented technologies. A potential strength lies in the inherent demand for advanced medical solutions. However, being listed on the OTC Other tier signals higher risk due to potentially limited liquidity and reporting requirements. Investors should closely monitor the company's ability to secure funding and achieve commercial success with its technologies.

Analyst Coverage for QMDT: QMDT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates QMDT against sector peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the QMDT film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Council Score · Weighted Average of 3 Disciplines
Split View 48/100 · C

QMDT: 1/2 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Simons-style lens (simulated)Jim Simons
Favorable read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Quick-Med Technologies, Inc. Company Overview

Data Provenance | Financial Data Quantitative Analysis

Research confidence

Low 20/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price is current
  • No filing on record
  • No analyst coverage

QMDT Current Price & Trading Activity

QMDT is currently trading at $0.00, with a daily change of +0.00 (+0.00%). The stock has a trading volume of 135K shares, which provides insight into market interest and liquidity for this security.

Analyst Coverage for QMDT

QMDT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model scores QMDT on quantitative fundamentals — growth, financial health, valuation, and momentum — relative to sector peers and assigns a neutral fundamental signal based on the underlying data. Investors monitoring QMDT should weigh peer-relative metrics and sector momentum more heavily until institutional coverage emerges.

Data sourced from Financial Modeling Prep, Yahoo Finance and SEC EDGAR. This content is generated from market data and is not financial advice. Past performance does not guarantee future results.

QMDT Latest News

No recent news available for QMDT.

QMDT Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for QMDT.

Price Targets

Wall Street price target analysis for QMDT.

QMDT MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for QMDT; grades run from A+ (80-100) to F (below 30).

QMDT OTC Market Information

QMDT trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

Investor Questions: QMDT Stock

Is QMDT a good stock?

Stock Expert AI does not rate QMDT buy, sell or hold. Quick-Med Technologies, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What are the key factors to evaluate for QMDT?

Evaluate QMDT on fundamentals, analyst consensus, and risk factors. Not financial advice.

How frequently does QMDT data refresh on this page?

QMDT's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven QMDT's recent stock price performance?

Quick-Med Technologies, Inc. (QMDT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider QMDT overvalued or undervalued right now?

Quick-Med Technologies, Inc. (QMDT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of QMDT?

Yes, most major brokerages offer fractional shares of Quick-Med Technologies, Inc. (QMDT) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track QMDT's earnings and financial reports?

Quick-Med Technologies, Inc. (QMDT) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for QMDT earnings announcements.

What should investors new to QMDT understand first?

Quick-Med Technologies, Inc. (QMDT) is worth researching across volatility, fundamentals, and industry context. With a market cap of $18.67K, its size is a factor in volatility characteristics. Start with the Company Overview and MoonshotScore tabs for a structured introduction.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

More Stocks We Cover